PetVivo Holdings, Inc. Announces
They Are Exhibiting at Western Veterinary
Conference
Minneapolis, MN
-- January 28, 2020 -- InvestorsHub NewsWire
-- PetVivo Holdings, Inc.
(OTCQB:
PETV) (the "Company") PetVivo Holdings, Inc.
(www.petvivo.com) an emerging biomedical device
company operating in the $18B
veterinary market announced today it will be exhibiting at the
Western Veterinary Conference from February 16th to February
19th, 2020 at the Mandalay Bay
Convention Center in Las Vegas, NV.
PetVivo is
excited to meet with many of the 15,000+ participants to talk about
its lead product, an injection of sterilized, hydrogel
microparticles
that are wet,
slippery and spongy for the treatment of osteoarthritis and
lameness originating in the joints of dogs and horses.
WVC
is
one of
the largest
veterinary conferences in the United States and
plays host to many of the industry's
top
professionals.
"We at PetVivo are excited to
network with
leaders in the industry and develop relationships that will help
drive our product forward," said John
Lai, CEO of PetVivo Holdings,
Inc.
For more
information about PetVivo, please contact info1@petvivo.com or visit https://petvivo.com/
Conference
Details:
Western Veterinary
Conference (WVC) Booth #: 4439
Dates:
Monday, February
17,
2020 9:00am – 6:00pm
Tuesday,
February
18,
2020 9:00am – 6:00pm
Wednesday,
February
19,
2020 9:00am – 2:00pm
About PetVivo
Holdings, Inc.
PetVivo
Holdings, Inc. (OTCQB:
PETV) is an emerging veterinary
biomedical
company focused on licensing and commercialization of
highly
innovative
medical technologies
for
companion animal
therapeutics.
PetVivo is leveraging investments made in the human medical device
industry to commercialize therapeutics for pets in a capital and
time efficient way. A key component of this strategy is the
accelerated timeline to revenues for veterinary medical
devices, and the opportunity to
bring products
into large
markets represented by currently unmet needs of our companion
animals.
Forward-Looking
commercial Statements:
The foregoing
material may contain forward-looking statements. We caution that
such statements may be subject to uncertainties and that actual
results could differ materially from the forward-looking
statements. Readers accordingly should not place undue reliance on
these forward-looking statements, which do not reflect unknown or
unanticipated events or circumstances occurring after the date of
these forward-looking statements
CONTACT:
John
Lai
President
&
CEO
PetVivo Holdings,
Inc.
Main:
952-405-6216